Literature DB >> 25597357

RKIP structure drives its function: a three-state model for regulation of RKIP.

John J Skinner1, Marsha Rich Rosner2.   

Abstract

Raf kinase inhibitory protein (RKIP) is a highly conserved regulator of many signaling networks whose loss or inactivation can lead to a variety of disease states. The multifaceted roles played by RKIP are enabled by an allosteric structure that is controlled through phosphorylation of RKIP and dynamics in the RKIP pocket loop. Perhaps the most striking feature of RKIP is that it can assume multiple functional states. Specifically, phosphorylation redirects RKIP from a state that binds and inhibits Raf-1 to a state that binds and inhibits GRK2. Recent evidence suggests the presence of a third functional state that facilitates RKIP phosphorylation. Here, we present a three-state model to explain the RKIP functional switch and discuss the role of the pocket loop in regulating RKIP activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25597357      PMCID: PMC4311871          DOI: 10.1615/critrevoncog.2014012001

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  30 in total

1.  A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration.

Authors:  Shoutian Zhu; Kevin T Mc Henry; William S Lane; Gabriel Fenteany
Journal:  Chem Biol       Date:  2005-09

2.  Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.

Authors:  Nicholas Trakul; Raymond E Menard; George R Schade; Zhijian Qian; Marsha Rich Rosner
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

3.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

4.  The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.

Authors:  Oliver Rath; Sungdae Park; Hui-hui Tang; Mark J Banfield; R Leo Brady; Yie Chia Lee; John D Dignam; John M Sedivy; Walter Kolch; Kam C Yeung
Journal:  Cell Signal       Date:  2008-01-24       Impact factor: 4.315

5.  Crystal structure of the phosphatidylethanolamine-binding protein from bovine brain: a novel structural class of phospholipid-binding proteins.

Authors:  L Serre; B Vallée; N Bureaud; F Schoentgen; C Zelwer
Journal:  Structure       Date:  1998-10-15       Impact factor: 5.006

6.  Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism.

Authors:  Alexey E Granovsky; Matthew C Clark; Dan McElheny; Gary Heil; Jia Hong; Xuedong Liu; Youngchang Kim; Grazyna Joachimiak; Andrzej Joachimiak; Shohei Koide; Marsha Rich Rosner
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

7.  Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease.

Authors:  Kenji Okita; Noriyuki Matsukawa; Mina Maki; Hideka Nakazawa; Eiichi Katada; Manabu Hattori; Hiroyasu Akatsu; Cesario V Borlongan; Kosei Ojika
Journal:  Biochem Biophys Res Commun       Date:  2008-12-25       Impact factor: 3.575

8.  Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.

Authors:  Surabhi Dangi-Garimella; Jieun Yun; Eva M Eves; Martin Newman; Stefan J Erkeland; Scott M Hammond; Andy J Minn; Marsha Rich Rosner
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

9.  Ligand binding study of human PEBP1/RKIP: interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry.

Authors:  Laurette Tavel; Lucie Jaquillard; Andreas I Karsisiotis; Fabienne Saab; Laurence Jouvensal; Alain Brans; Agnès F Delmas; Françoise Schoentgen; Martine Cadene; Christian Damblon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Regulation of RKIP function by Helicobacter pylori in gastric cancer.

Authors:  Erika L Moen; Sicheng Wen; Talha Anwar; Sam Cross-Knorr; Kate Brilliant; Faith Birnbaum; Sherida Rahaman; John M Sedivy; Steven F Moss; Devasis Chatterjee
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more
  7 in total

1.  Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop.

Authors:  Jiyoung Lee; Cristina Olivieri; Colin Ong; Larry R Masterson; Suzana Gomes; Bok-Soon Lee; Florian Schaefer; Kristina Lorenz; Gianluigi Veglia; Marsha Rich Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-13       Impact factor: 12.779

Review 2.  G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.

Authors:  Cristina Murga; Alba C Arcones; Marta Cruces-Sande; Ana M Briones; Mercedes Salaices; Federico Mayor
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 3.  The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment.

Authors:  Hannah Cessna; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

4.  Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.

Authors:  Yang Wang; Juan-Juan Chen; Xiao-Fei Wang; Qiang Wang
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

Review 5.  Targeting Raf Kinase Inhibitory Protein Regulation and Function.

Authors:  Ali Ekrem Yesilkanal; Marsha Rich Rosner
Journal:  Cancers (Basel)       Date:  2018-09-04       Impact factor: 6.639

Review 6.  Insights of RKIP-Derived Suppression of Prostate Cancer.

Authors:  Ying Dong; Xiaozeng Lin; Anil Kapoor; Yan Gu; Hui Xu; Pierre Major; Damu Tang
Journal:  Cancers (Basel)       Date:  2021-12-20       Impact factor: 6.639

Review 7.  RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

Authors:  Roni Touboul; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.